Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,476 INR | +0.06% | -0.28% | -12.22% |
Feb. 09 | India's Zydus Lifesciences beats Q3 profit estimates; approves shares buyback | RE |
Feb. 08 | Transcript : Zydus Wellness Limited, Q3 2024 Earnings Call, Feb 08, 2024 |
Sales 2024 * | 23.19B 278M | Sales 2025 * | 26.27B 315M | Capitalization | 93.72B 1.12B |
---|---|---|---|---|---|
Net income 2024 * | 2.9B 34.86M | Net income 2025 * | 3.95B 47.38M | EV / Sales 2024 * | 4.02 x |
Net cash position 2024 * | 566M 6.79M | Net cash position 2025 * | 2.8B 33.56M | EV / Sales 2025 * | 3.46 x |
P/E ratio 2024 * |
31.5
x | P/E ratio 2025 * |
23.7
x | Employees | 975 |
Yield 2024 * |
0.5% | Yield 2025 * |
0.7% | Free-Float | 20.11% |
Latest transcript on Zydus Wellness Limited
1 day | +0.06% | ||
1 week | -0.28% | ||
Current month | -5.86% | ||
1 month | -6.27% | ||
3 months | -10.20% | ||
6 months | -5.71% | ||
Current year | -12.22% |
Managers | Title | Age | Since |
---|---|---|---|
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 15-05-13 |
Umesh V. Parikh
DFI | Director of Finance/CFO | - | 18-02-06 |
Nandish Joshi
CMP | Compliance Officer | - | 22-07-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 09-04-26 | |
Tarun G. Arora
CEO | Chief Executive Officer | 52 | 15-05-13 |
Director/Board Member | 50 | 19-03-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1,476 | +0.06% | 26 923 |
24-03-27 | 1,475 | -1.08% | 85,085 |
24-03-26 | 1,491 | -0.19% | 23,149 |
24-03-22 | 1,494 | +0.95% | 19,081 |
24-03-21 | 1,480 | -1.36% | 56,137 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.06% | 278B | |
-3.22% | 94.39B | |
-1.22% | 44.41B | |
+1.99% | 41.48B | |
+3.90% | 39.56B | |
+6.94% | 39.33B | |
-12.78% | 32.12B | |
-1.36% | 29.71B | |
+5.20% | 23.78B |
- Stock
- Equities
- Stock Zydus Wellness Limited
- Stock Zydus Wellness Limited - NSE India S.E.